Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan

Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis

NCT00650026 ·Status: APPROVED_FOR_MARKETING

A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia

NCT01387789 ·Status: COMPLETED

Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases

NCT03339089 ·Status: COMPLETED

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

NCT00235872 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.

NCT00195702 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab

NCT00650390 ·Status: APPROVED_FOR_MARKETING

Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

NCT00235859 ·Status: COMPLETED ·Phase: PHASE3

Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab

NCT02627924 ·Status: COMPLETED

Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab

NCT01752855 ·Status: COMPLETED ·Phase: PHASE2

Post-marketing Observational Study in Subjects With Rheumatoid Arthritis

NCT00234884 ·Status: COMPLETED

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

NCT00235833 ·Status: COMPLETED ·Phase: PHASE2

A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis

NCT00233571 ·Status: COMPLETED ·Phase: PHASE3

Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease

NCT01893996 ·Status: COMPLETED ·Phase: PHASE4

Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)

NCT01346488 ·Status: COMPLETED

Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice

NCT01077258 ·Status: COMPLETED

Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis

NCT00649545 ·Status: APPROVED_FOR_MARKETING

A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis

NCT00448383 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice

NCT01078090 ·Status: COMPLETED

Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents

NCT01783730 ·Status: COMPLETED

Rheumatoid Arthritis Satisfaction Outcome Research

NCT03703817 ·Status: COMPLETED

A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety

NCT01712178 ·Status: COMPLETED ·Phase: PHASE2

Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice

NCT01736189 ·Status: COMPLETED

Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis

NCT00646386 ·Status: COMPLETED ·Phase: PHASE2

Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis

NCT03110094 ·Status: COMPLETED ·Phase: NA

Long Term Open Label Continuation Study

NCT00195650 ·Status: COMPLETED ·Phase: PHASE3